Intranasal insulin improves cognition and modulates β-amyloid in early AD
NeurologyPublished 18 October 2007
Mark A. Reger, G. Stennis Watson, P. S. Green, Charles W. Wilkinson, Laura D. Baker, Brenna Cholerton
Citations821
SJR quartileQ1
SJR score2.40
SNIP1.82
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The results of this pilot study support further investigation of the benefits of intranasal insulin for patients with Alzheimer disease, and suggest that intran asal peptide administration may be a novel approach to the treatment of neurodegenerative disorders.
Abstract
The results of this pilot study support further investigation of the benefits of intranasal insulin for patients with Alzheimer disease, and suggest that intranasal peptide administration may be a novel approach to the treatment of neurodegenerative disorders.
Keywords
Biochemistry, Genetics and Molecular BiologyNeuroscienceNursing
NatureCentral nervous system control of food intake
6,409 Citations2000Michael W. Schwartz, Stephen C. Woods +3 more
A model is described that delineates the roles of individual hormonal and neuropeptide signalling pathways in the control of food intake and the means by which obesity can arise from inherited or acquired defects in their function.
The LancetMild cognitive impairment
3,865 Citations2006Serge Gauthier, Barry Reisberg +17 more
Although there are no pharmacological treatments at present that are capable of delaying the long-term progression of MCI to dementia, there is some evidence of short-term symptomatic benefits with acetylcholinesterase inhibitors.
NatureCentral nervous system control of food intake and body weight
2,465 Citations2006Gregory J. Morton, D. E. Cummings +3 more
This new information provides a biological context within which to consider the global obesity epidemic and identifies numerous potential avenues for therapeutic intervention and future research.
Biological PsychiatryNeurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
932 Citations2005Amy F.T. Arnsten, Bao-Ming Li
Blockade of norepinephrine alpha-2-adrenoceptors in prefrontal cortex markedly impairs prefrontal cortex function and mimics most of the symptoms of attention-deficit/hyperactivity disorder, including impulsivity and locomotor hyperactivity.
NeuroscienceDelivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration
922 Citations2004Robert G. Thorne, Gijsbertus J. Pronk +2 more
The Lancet NeurologyInsulin and neurodegenerative disease: shared and specific mechanisms
815 Citations2004Suzanne Craft, G. Stennis Watson
PsychoneuroendocrinologyIntranasal insulin improves memory in humans
675 Citations2004Christian Benedict, Manfred Hallschmid +5 more
Results indicate a direct action of prolonged intranasal administration of insulin on brain functions, improving memory and mood in the absence of systemic side effects, which could be of relevance for the treatment of patients with memory disorders like in Alzheimer's disease.
Journal of Experimental Psychology Human Perception & PerformanceStroop performance in healthy younger and older adults and in individuals with dementia of the Alzheimer's type.
623 Citations1996Daniel H. Spieler, David A. Balota +1 more
The results indicate that older adults show a disproportionate increase in interference compared with younger adults, which is consistent with an inhibitory breakdown in normal aging and an accelerated breakdown in inhibition in DAT individuals.
Neurobiology of AgingEffects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype
618 Citations2005Mark A. Reger, G. Stennis Watson +10 more
It is suggested that intranasal insulin administration may have therapeutic benefit without the risk of peripheral hypoglycemia and further evidence for apolipoprotein E (APOE) related differences in insulin metabolism is provided.
Journal of NeuroscienceGlucocorticoids Increase Amyloid-β and Tau Pathology in a Mouse Model of Alzheimer’s Disease
614 Citations2006Kim N. Green, Lauren M. Billings +3 more
It is reported that stress-level glucocorticoid administration increases Aβ formation by increasing steady-state levels of amyloid precursor protein (APP) and β-APP cleaving enzyme and augments tau accumulation, indicating that this hormone also accelerates the development of neurofibrillary tangles.
NeurologyCerebrospinal fluid and plasma insulin levels in Alzheimer's disease
560 Citations1998Suzanne Craft, Elaine R. Peskind +4 more
Patients with Alzheimer's disease have elevations of fasting plasma insulin that are hypothesized to be associated with disrupted brain insulin metabolism, and there are metabolic differences among apolipoprotein E genotypes.
Journal of Clinical InvestigationCentral insulin action in energy and glucose homeostasis
435 Citations2006Leona Plum
Insulin's role as a central homeostatic signal with regard to energy and glucose homeostasis is reviewed and the mechanisms by which insulin communicates information about the body's energy status to the brain are discussed.
NeurologyPlasma Aβ40 and Aβ42 and Alzheimer’s disease
435 Citations2003R. Mayeux, Lawrence S. Honig +5 more
High plasma A[beta]42 levels may also be associated with mortality in patients with AD, and these levels increase with age and are strongly correlated with each other.
European Journal of PharmacologyGlucose metabolism and insulin receptor signal transduction in Alzheimer disease
429 Citations2004Siegfried Hoyer
In late-onset sporadic Alzheimer disease changes in the brain are similar to those caused by non-insulin-dependent diabetes mellitus, and disturbances in the neuronal insulin signal transduction pathway may be of central pathophysiological significance.
Journal of NeurochemistryPresenilin clinical mutations can affect γ‐secretase activity by different mechanisms
410 Citations2006Mostafa Bentahir, Omar Nyabi +6 more
Overall, the results indicate that the different mutations in PS affect γ‐secretase structure or function in multiple ways.
Journal of NeuroscienceInsulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention
324 Citations2004Lixia Zhao, Bruce Teter +6 more
In vitro and in vivo analyses validate the use of enhanced CNS insulin signaling as a potential strategy for AD intervention to correct the IDE defects occurring in AD.
Human MutationMean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40
321 Citations2006Samir Kumar‐Singh, Jessie Theuns +8 more
The data suggested that Ab40 might be protective by perhaps sequestering the more toxic Ab42 and facilitating its clearance, and the in vitro method described here is a valid tool for assaying the pathogenic potential of clinical PSEN mutations in a molecular diagnostic setting.
DiabetesObesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs.
319 Citations2000Karl J. Kaiyala, R L Prigeon +3 more
It is demonstrated that increased food intake and weight gain during high-fat feeding are associated with and may be causally related to reduced insulin delivery into the CNS.
Journal of Steroid BiochemistryClinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin
286 Citations1987Jean-Luc Coolens, Hugo Van Baelen +1 more
It is concluded that unbound cortisol can be calculated in a simple and reliable way from total cortisol and CBG and permits a better evaluation of adrenal function, particularly in patients with altered CBG concentrations.
Nature Clinical Practice NeurologyTherapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease
284 Citations2006Mary N. Haan
Clinical implications of the T2 DM–AD link include cognitive evaluations of patients with T2DM, and potential benefits for such patients through treatment with statins or diabetes drugs that target insulin.
PsychoneuroendocrinologyInsulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype
254 Citations2003Suzanne Craft, Sanjay Asthana +11 more
A role for insulin in normal memory and APP modulation that follows a curvilinear response pattern is supported, and it is suggested that AD patients who are not epsilon 4 homozygotes have reduced sensitivity to insulin that may interfere with such modulation.
Alzheimer Disease & Associated DisordersPerformance of the Dementia Severity Rating Scale: A Caregiver Questionnaire for Rating Severity in Alzheimer Disease
223 Citations1996Christopher Clark, Douglas C. Ewbank
The Dementia Severity Rating Scale (DSRS) is an informant-based, multiple- choice questionnaire that assesses severity from the mildest to the most severe stages in the major functional and cognitive domains affected in Alzheimer disease.
Archives of NeurologyHyperinsulinemia Provokes Synchronous Increases in Central Inflammation and β-Amyloid in Normal Adults
219 Citations2005Mark A. Fishel, G. Stennis Watson +13 more
Moderate hyperinsulinemia can elevate inflammatory markers and Abeta42 in the periphery and the brain, thereby potentially increasing the risk of Alzheimer disease.
DiabetesPeripheral Hyperinsulinemia Promotes Tau Phosphorylation In Vivo
147 Citations2005S Freude, Leona Plum +6 more
Journal of Neuropathology & Experimental NeurologyEffects of Chronic Glucocorticoid Administration on Insulin-Degrading Enzyme and Amyloid-Beta Peptide in the Aged Macaque
95 Citations2005J. Jacob Kulstad, Pamela J. McMillan +8 more
Findings support the notion that glucocorticoids regulate IDE and provide a mechanism whereby increased glucoc Corticoid levels may contribute to AD pathology.
Journal of Aerosol MedicineBi-Directional Nasal Delivery of Aerosols Can Prevent Lung Deposition
93 Citations2004Per G. Djupesland, Arne Skretting +2 more
The bi-directional nasal delivery concept minimizes the risks and problems related to lung deposition occurring during conventional nasal inhalation from a nebulizer and opens up a new range of opportunities for nasal delivery of drugs and vaccines.
Alzheimer Disease & Associated DisordersObservations and Suggestions on Antidementia Drug Development
86 Citations1996Paul Leber
Two clinical trial designs are reviewed and compared that may prove useful in assessing whether or not a putative treatment actually modifies the course of dementia.
NeurologyDifferential modulation of plasma β-amyloid by insulin in patients with Alzheimer disease
82 Citations2006J. Jacob Kulstad, P. S. Green +9 more
It is suggested that patients with Alzheimer disease (AD) have reduced insulin clearance and insulin-provoked plasma amyloid β-peptide (Aβ) elevation, which may contribute to AD risk.
Alzheimer Disease & Associated DisordersWord List Versus Story Memory in Alzheimer Disease and Frontotemporal Dementia
78 Citations2006Alissa Wicklund, Nancy Johnson +3 more
Patterns of performance on different tests of memory, and, in particular, measures of retention, can be useful in differentiating memory impairment in AD from that of FTD on cognitive testing are suggested.